Study Strengthens Link between Vaginal Mesh and Risk for Complications

Defective Medical Devices

Makes of transvaginal mesh products are already facing lawsuits from women who received vaginal mesh for the treatment of pelvic organ prolapse (POP) or stress urinary incontinence (SUI) and later experienced painful complications; the results of a new study seem to strengthen the argument that transvaginal mesh is a defective medical device.

An increasing number of patient complaints in recent years have complained of early failure rates and side-effects after receiving transvaginal mesh, which is intended to help support the pelvic organs following surgical treatment of POP or SUI. The results of a study published in the May 15 edition of The Journal of the American Medical Association seem to confirm that vaginal mesh has a high risk of erosion that can lead to organ perforation and other complications, as well as necessitate revision surgery.

Other complications linked to transvaginal mesh include:

  • Infections
  • Internal bleeding
  • Pain during urination or intercourse
  • Vaginal pain
  • Vaginal scarring

The study reported in The Journal of the American Medical Association did not single out specific models or manufacturers of transvaginal mesh. Makers of these potentially defective medical products include:

  • American Medical Systems
  • Boston Scientific
  • C.R. Bard
  • Covidien
  • Ethicon
  • Johnson & Johnson